Medpace Holdings, Inc. Common Stock
Symbol: MEDP (NASDAQ)
526.52
▼ (-1.80%) -9.650
Company Description:
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Key Stats
- Today's Open: $535.35
- Today's High: $540.35
- Today's Low: $519.015
- Today's Volume: 292.59K
- Yesterday Close: $536.17
- Yesterday High: $542.43
- Yesterday Low: $521.84
- Yesterday Volume: 468.64K
- Last Min Volume: 6
- Last Min High: $526.52
- Last Min Low: $526.52
- Last Min VWAP: $526.52
Company Profile
- Name: Medpace Holdings, Inc. Common Stock
- Website: https://www.medpace.com
- Listed Date: 2016-08-11
- Location: CINCINNATI, OH
- Market Status: Active
- CIK Number: 0001668397
- SIC Code: 8731
- SIC description: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
- Market Cap: $14.96B
- Round Lot: 100
- Outstanding Shares: 28.09M
- Asset Type: CS
RECENT FILINGS FOR MEDP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-02 | 4 | View |
| 2025-10-02 | 4 | View |
| 2025-10-02 | 4 | View |
| 2025-09-30 | 4 | View |
| 2025-09-05 | 4 | View |
| 2025-09-03 | 144 | View |
| 2025-09-03 | 4 | View |
| 2025-08-28 | 144/A | View |
| 2025-08-28 | 4 | View |
| 2025-08-28 | 4 | View |
| 2025-08-27 | 144 | View |
| 2025-08-21 | 4 | View |
| 2025-08-19 | 144 | View |
| 2025-07-29 | 4 | View |
| 2025-07-29 | 4 | View |
| 2025-07-29 | 4 | View |
| 2025-07-28 | 4 | View |
| 2025-07-28 | 4 | View |
| 2025-07-28 | 144 | View |
| 2025-07-28 | 144 | View |